GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » EV-to-EBIT

Nuvation Bio (Nuvation Bio) EV-to-EBIT : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nuvation Bio's Enterprise Value is $0.00 Mil. Nuvation Bio's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-93.32 Mil. Therefore, Nuvation Bio's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Nuvation Bio's EV-to-EBIT or its related term are showing as below:

NUVB.WS' s EV-to-EBIT Range Over the Past 10 Years
Min: -52.54   Med: 0   Max: 0
Current: -11.86
NUVB.WS's EV-to-EBIT is not ranked
in the Biotechnology industry.
Industry Median: 8.19 vs NUVB.WS: -11.86

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nuvation Bio's Enterprise Value for the quarter that ended in Sep. 2021 was $0.00 Mil. Nuvation Bio's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-93.32 Mil. Nuvation Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 was %.

Nuvation Bio EV-to-EBIT Historical Data

The historical data trend for Nuvation Bio's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio EV-to-EBIT Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
EV-to-EBIT
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-EBIT Get a 7-Day Free Trial - -77.76 -29.31 -21.55 -

Competitive Comparison of Nuvation Bio's EV-to-EBIT

For the Biotechnology subindustry, Nuvation Bio's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's EV-to-EBIT falls into.


Nuvation Bio EV-to-EBIT Calculation

Nuvation Bio's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-93.318
=0.00

Nuvation Bio's current Enterprise Value is $0.00 Mil.
Nuvation Bio's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-93.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio  (NYSE:NUVB.WS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nuvation Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2021 ) =EBIT / Enterprise Value (Q: Sep. 2021 )
=-93.318/0
= %

Nuvation Bio's Enterprise Value for the quarter that ended in Sep. 2021 was $0.00 Mil.
Nuvation Bio's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-93.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » EV-to-EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.